With an aim to focus on the sales and marketing of biotech drugs, oncology as well as plasma products, Intas Biopharmaceuticals Limited (IBPL) has launched three new sales divisions, Track, Aqua and Relay. The sales and marketing of the drugs through Track, Aqua and Relay is aimed to cater to solid tumours, haematology and supportive therapies respectively. The segregation of sales divisions, based on therapeutic segments, is aimed to increase focus and penetration of Oncology products in the domestic market.
